OPTIMIZING THE DURATION OF MONITORING WITH THE DIAGNOSTIC YIELD FOR BRADYARRHYTHMIAS USING A NEXT GENERATION, FULL-DISCLOSURE MOBILE CARDIAC TELEMETRY DEVICE

Full-disclosure, mobile cardiac telemetry (MCT) devices provide continuous ECG data transfer and rhythm identification for up to 30-days providing newer methods to identify high risk patients. Determining the optimal monitoring duration has significant healthcare quality and cost implications. The